Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
Damaskos C, Tomos I, Garmpis N, Karakatsani A, Dimitroulis D, Garmpi A, Spartalis E, Kampolis CF, Tsagkari E, Loukeri AA, Margonis GA, Spartalis M, Andreatos N, Schizas D, Kokkineli S, Antoniou EA, Nonni A, Tsourouflis G, Markatos K, Kontzoglou K, Kostakis A, Tomos P. Damaskos C, et al. Among authors: nonni a. Anticancer Res. 2018 Jan;38(1):37-43. doi: 10.21873/anticanres.12189. Anticancer Res. 2018. PMID: 29277754 Review.
Is there an association between thyroid function abnormalities and breast cancer?
Angelousi A, Diamanti-Kandarakis E, Zapanti E, Nonni A, Ktenas E, Mantzou A, Kontzoglou K, Kouraklis G. Angelousi A, et al. Among authors: nonni a. Arch Endocrinol Metab. 2017 Jan-Feb;61(1):54-61. doi: 10.1590/2359-3997000000191. Epub 2016 Aug 25. Arch Endocrinol Metab. 2017. PMID: 28273204 Free PMC article.
Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises.
Garmpis N, Damaskos C, Garmpi A, Kalampokas E, Kalampokas T, Spartalis E, Daskalopoulou A, Valsami S, Kontos M, Nonni A, Kontzoglou K, Perrea D, Nikiteas N, Dimitroulis D. Garmpis N, et al. Among authors: nonni a. Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):299-313. doi: 10.21873/cgp.20041. Cancer Genomics Proteomics. 2017. PMID: 28870998 Free PMC article. Review.
Targeting histone deacetylases in endometrial cancer: a paradigm-shifting therapeutic strategy?
Garmpis N, Damaskos C, Garmpi A, Spartalis E, Kalampokas E, Kalampokas T, Margonis GA, Schizas D, Andreatos N, Angelou A, Lavaris A, Athanasiou A, Apostolou KG, Spartalis M, Damaskou Z, Daskalopoulou A, Diamantis E, Tsivelekas K, Alavanos A, Valsami S, Moschos MM, Sampani A, Nonni A, Antoniou EA, Mantas D, Tsourouflis G, Markatos K, Kontzoglou K, Perrea D, Nikiteas N, Kostakis A, Dimitroulis D. Garmpis N, et al. Among authors: nonni a. Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):950-960. doi: 10.26355/eurrev_201802_14376. Eur Rev Med Pharmacol Sci. 2018. PMID: 29509243 Review.
Histone deacetylase inhibitors as a new anticancer option: How far can we go with expectations? delivery systems.
Garmpi A, Garmpis N, Damaskos C, Valsami S, Spartalis E, Lavaris A, Patelis N, Margonis GA, Apostolou KG, Spartalis M, Andreatos N, Diamantis E, Tsivelekas K, Moschos MM, Nonni A, Tsourouflis G, Markatos K, Antoniou EA, Kontzoglou K, Nikiteas N, Dimitroulis D. Garmpi A, et al. Among authors: nonni a. J BUON. 2018 Jul-Aug;23(4):846-861. J BUON. 2018. PMID: 30358185 Free article.
115 results